Publication
Article
Pharmacy Times
Author(s):
Products include deodorant and pain medication that uses a plant-based formula.
Native has released a line of deodorants that double as all-over fragrance sprays. They offer a fine nitrogen-powered mist made with a natural, ozone-friendly propellant. Ingredients include caprylic triglyceride, denatured alcohol, and dipropylene glycol. Each spray is free from aluminum, hydrocarbons, and parabens, according to the product website. Scents, including coconut and vanilla, derive from a blend of essential oils, synthetic oils, and natural extracts free of phthalates.
For More Information:
nativecos.com
For More Information:
preservision.com
Natural pain relief capsules from Medterra are a daily supplement made with a 100% plant-based formula, according to the product website. The natural, vegan ingredients include Levagen+ PEA and turmeric. Levagen+ PEA is a special form of palmitoylethanolamide (PEA) clinically proven to reduce pain in as little as 3 days, according to Medterra. Together, these ingredients combat inflammation, promote whole body health, reduce joint stiffness, and support muscle recovery. The product should be taken once daily over a prolonged period to ensure maximum effectiveness. The supplements do not cause adverse effects, according to Medterra.
For More Information:
medterracbd.com
OLAY now offers Regenerist Niacinamide + Peptide 24 Face Moisturizer made with 99% pure niacinamide to improve the skin’s moisture barrier. The hydrating moisturizer is designed to absorb quickly without greasy residue for use under makeup. The product is made without parabens, phthalates, or synthetic dyes, and it has a light fragrance. The moisturizer can be used after cleansing, both morning and night, on the face and neck. It should be worn with sun protection factor for daytime use. The moisturizer improves the complexion, reduces wrinkles, and strengthens the hydration barrier with prolonged use, according to the company.
For More Information:
olay.com
FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara